6095 Evaluation of the novel SPIO GEH 121333 for monitoring changes in tumor vascularity and vascular permeability after anti-angiogenic treatment using susceptibility contrast and T 1-mapping

Evaluation of the novel SPIO GEH121333 for monitoring changes in tumor vascularity and vascular permeability after antiangiogenic treatment using susceptibility contrast and T1-mapping Else Marie Huuse, Jana Cebulla, Dan E Meyer, Karina Langseth, Siver Andre Moestue, and Tone Frost Bathen Department of medical Imaging, St. Olavs University Hospital, Trondheim, Norway, MI lab and Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, Biomedical Imaging & Physiology Laboratory, GE Global Research Center, Niskayuna, NY, United States, GE Healthcare AS, Oslo, Norway